Articles

The cancer patient who develops malglycemia (another word for hyperglycemia experienced by nondiabetic patients)—either due to cancer itself or to drugs patients take for their cancer—is somewhat of a “hot potato.” Read More ›

Oral chemotherapy presents unique issues, including safety and toxicity, and advance planning is essential. Read More ›

True mentoring is more than just answering occasional questions or providing ad hoc help. Read More ›

Two orally available experimental drugs achieved response in patients with BRCA-deficient solid tumors in a phase 1 study of 38 patients. Read More ›

Comprehensive genetic analysis by The Cancer Genome Atlas (TCGA) identified 4 different subtypes of squamous cell carcinoma of the head and neck (SCCHN). Read More ›

Real-life experience translated into a research interest for Fedricker Barber, RN, ANP, AOCNP, of the MD Anderson Cancer Center in Houston, Texas. Read More ›

Evidence suggests that cancer patients commonly experience spiritual pain or distress but believe that their spiritual needs are not being adequately addressed by healthcare providers. Read More ›

Prostate cancer screening with prostate-specific antigen (PSA) tests should focus on men aged 55 to 69 years, the group that is the most likely to benefit from screening. Read More ›

Vemurafenib is a relatively new effective option for the treatment of melanoma, but most patients who respond will develop resistance. Read More ›

Study shows that mothers strive to educate their children by sharing genetic testing results. Read More ›